Form 4: Nuvation Bio Director Transfers Options to Trust

Nuvation Bio Inc. Director and 10% owner Robert Mashal transferred 350,001 vested stock options to an irrevocable trust.

Summary

• Robert Mashal, a Director and 10% owner of Nuvation Bio Inc. (NUVB), transferred 350,001 stock options to an irrevocable trust.
• The transaction occurred on August 11, 2025, and was reported via a Form 4 filing on August 13, 2025.
• The transferred stock options are fully vested and have an exercise price of $1.55 per share.
• The options are for Class A Common Stock and are set to expire on January 7, 2034.
• The transfer was reported with a transaction code 'G', indicating a gift or non-sale disposition, with a price of $0 for the derivative security.

Sentiment

Score: 5

Explanation: The filing reports a routine personal financial transaction by a director, which has no direct positive or negative implications for the company's operational or financial performance.

Positives

• The transfer of stock options to an irrevocable trust is a common and routine personal estate planning strategy for high-net-worth individuals, including corporate directors.

Negatives

• No direct negative implications for Nuvation Bio Inc.'s operational or financial performance are indicated by this personal transaction.

Future Outlook

No forward-looking statements or guidance regarding Nuvation Bio Inc.'s future performance or strategy are provided in this filing.

Industry Context

This filing details a personal financial transaction by a director and does not provide information relevant to broader industry trends or competitive dynamics within the biotechnology or pharmaceutical sectors.

Related Party Transactions

• The transaction involves the transfer of stock options by a director to his irrevocable trust, which is a related party for beneficial ownership reporting purposes.

Stakeholder Impact

• Minimal direct impact on shareholders, as this is a personal estate planning transaction by a director and does not affect the company's operations or capital structure.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The filing details a personal estate planning transaction by a director and does not contain information relevant to the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation.

Keywords

Nuvation Bio, NUVB, Robert Mashal, SEC Form 4, Stock Options, Trust, Insider Transaction, Corporate Governance, Director, 10% Owner